Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 10:01 PM
Study NCT ID:
NCT04286958
Status:
UNKNOWN
Last Update Posted:
2021-12-10
First Post:
2020-02-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Camrelizumab As Consolidation Therapy After Radical Concurrent Chemoradiotherapy In Locally Advanced ESCC
Sponsor:
Hebei Medical University Fourth Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-22
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-02-25
First Submit QC Date:
None
Study First Post Date:
2020-02-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-08
Last Update Post Date:
2021-12-10
Last Update Post Date Type:
ACTUAL